3MURO K,BOKU N,SHIMADA Y,et al.Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer:a randomised phase 2/3 non-inferiority study[J].Lancet Oncol,2010,11(9):853-860.
4OOSTENDORP L J,STALMEIER P F,PASKER-DE J P C,et al.Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer[J].Anticancer Drugs,2010,21(8):749-758.
5FUCHS C S,MARSHALL J,BARRUECO J.Randomized,controlled trial of irinotecan plus infusional,bolus,or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer:results from the BICC-C study[J].J Clin Oncol,2007,24(24):4779-4786.
6FUJITA K,SPARREBOOM A.Pharmacogenetics of irinotecan disposition and toxicity:a review[J].Curr Clin Pharmacol,2010,5(3):209-217.